Parmis, Viviana L.
HRN: 17-43-67 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
CEFTRIAXONE 1G (VIAL)
05/25/2023
06/01/2023
IV
2g
OD
Complicated UTI
Checking Final Appropriateness
05/29/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/29/2023
06/08/2023
IV
500mg
TID
Empiric
Checking Final Appropriateness